SCHEMBL1870326

SCHEMBL1870326

O=C(NS(=O)(=O)c1ccc(NCC2CCC3(CC2)COC3)c([N+](=O)[O-])c1)c1ccccc1Oc1cnc2[nH]ccc2c1

nearest known ligand 0.66

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ BCL2 P10415 20/20 0.66
▸ BCL2L1 Q07817 4/20 0.65

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29796456 1.00 BCL2 (0.66) BCL2BCL2L1
SCHEMBL29403314 0.93 BCL2 (0.74) BCL2BCL2L1
SCHEMBL1871052 0.93 BCL2 (0.74) BCL2BCL2L1
SCHEMBL29796421 0.92 BCL2 (0.67) BCL2BCL2L1
SCHEMBL29930979 0.92 BCL2 (0.75) BCL2BCL2L1
SCHEMBL29796237 0.90 BCL2 (0.68) BCL2BCL2L1
SCHEMBL29796374 0.90 BCL2 (0.71) BCL2BCL2L1
SCHEMBL29657489 0.90 BCL2 (0.69) BCL2BCL2L1
SCHEMBL1871300 0.90 BCL2 (0.69) BCL2BCL2L1
SCHEMBL29796430 0.89 BCL2 (0.66) BCL2BCL2L1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2435432-A2 APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES Abbott Laboratories (US) 2012-04-04 — — EP claimed
WO-2010138588-A9 APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES ABBOTT LABORATORIES (US) 2011-05-05 — — WO claimed
WO-2010138588-A2 APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES ABBOTT LABORATORIES (US) 2010-12-02 — — WO claimed
Send feedback